PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
VOR Vor Biopharma
- 1.370
- +0.040+3.01%
Close Feb 14 16:00 ET
- 1.369
- -0.001-0.09%
Post 20:01 ET
170.95MMarket Cap-0.84P/E (TTM)
1.380High1.310Low261.22KVolume1.320Open1.330Pre Close350.46KTurnover0.67%Turnover RatioLossP/E (Static)124.78MShares2.43052wk High2.34P/B53.33MFloat Cap0.63052wk Low--Dividend TTM38.93MShs Float63.620Historical High--Div YieldTTM5.26%Amplitude0.630Historical Low1.341Avg Price1Lot Size
Vor Biopharma Stock Forum
Sign in to post a comment
$Vor Biopharma (VOR.US)$ Vor Bio Announces Research On Barriers To Cell And Gene Therapy Clinical Trial Enrollment, Citing Complexity, Logistical Challenges, And Resource Constraints; Findings Presented At TANDEM Meetings Highlight Need For Improved Patient Experience.
Benzinga· 2 mins ago
Clinical trial complexity, logistical challenges associated with treatments, and resource constraints at trial sites cited as top factors that delay enrollment into cell and gene therapy (CGT) clinical tr...
Benzinga· 2 mins ago
Clinical trial complexity, logistical challenges associated with treatments, and resource constraints at trial sites cited as top factors that delay enrollment into cell and gene therapy (CGT) clinical tr...
2
3
$Vor Biopharma (VOR.US)$ repricing stock option will have bad impact for VOR bio ... ?
$Vor Biopharma (VOR.US)$ Im keep loading, bit by bit.
2
1
$Vor Biopharma (VOR.US)$ Incoming 🚀🚀🚀
2
3
$Vor Biopharma (VOR.US)$ be quiet.. slow slow slowly
2
$Vor Biopharma (VOR.US)$ Its time.
1
1
$Vor Biopharma (VOR.US)$
Was watching this Friday painting a beautiful chart not sure why I didn't enter but I will likely enter Monday.
Was watching this Friday painting a beautiful chart not sure why I didn't enter but I will likely enter Monday.
2
4
$Vor Biopharma (VOR.US)$ be quiet 🤫🤫🤫
1
4
$Vor Biopharma (VOR.US)$
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
...
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
...
2
1
No comment yet
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!
时刻警惕 : Good news or bad news.
Trytosaveabit OP 时刻警惕 : Both! Should be good longer term
时刻警惕 Trytosaveabit OP : Thank you, hoping everyone will work together and thrive.